-
1
-
-
58149376548
-
Molecular mechanisms of hepatocellular carcinoma
-
Aravalli R. N, Steer C. J, and Cressman E.N. Molecular mechanisms of hepatocellular carcinoma. Hepatology, 2008. 48(6): 2047-63.
-
(2008)
Hepatology
, vol.48
, Issue.6
, pp. 2047-2063
-
-
Aravalli, R.N.1
Steer, C.J.2
Cressman, E.N.3
-
2
-
-
54449083925
-
Molecular targeted therapies in hepatocellular carcinoma
-
Llovet J. M and Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology, 2008. 48(4): 1312-27.
-
(2008)
Hepatology
, vol.48
, Issue.4
, pp. 1312-1327
-
-
Llovet, J.M.1
Bruix, J.2
-
3
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin D. M, Bray F, Ferlay J, and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin, 2005. 55(2): 74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
4
-
-
18844447432
-
Liver transplantation for hepatocellular carcinoma
-
Befeler A. S, Hayashi P. H, and Di Bisceglie A.M. Liver transplantation for hepatocellular carcinoma. Gastroenterology, 2005. 128(6): 1752-64.
-
(2005)
Gastroenterology
, vol.128
, Issue.6
, pp. 1752-1764
-
-
Befeler, A.S.1
Hayashi, P.H.2
Di Bisceglie, A.M.3
-
5
-
-
42949174616
-
Diagnosis and treatment of hepatocellular carcinoma
-
El-Serag H. B, Marrero J. A, Rudolph L, and Reddy K.R. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology, 2008. 134(6): 1752-63.
-
(2008)
Gastroenterology
, vol.134
, Issue.6
, pp. 1752-1763
-
-
El-Serag, H.B.1
Marrero, J.A.2
Rudolph, L.3
Reddy, K.R.4
-
6
-
-
39549113180
-
Recurrence of hepatocellular carcinoma following liver transplantation: A review of preoperative and postoperative prognostic indicators
-
Zimmerman M. A, Ghobrial R. M, Tong M. J, Hiatt J. R, Cameron A. M, Hong J, et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg, 2008. 143(2): 182-8.
-
(2008)
Arch Surg
, vol.143
, Issue.2
, pp. 182-188
-
-
Zimmerman, M.A.1
Ghobrial, R.M.2
Tong, M.J.3
Hiatt, J.R.4
Cameron, A.M.5
Hong, J.6
-
7
-
-
0345601083
-
Met, metastasis, motility and more
-
Birchmeier C, Birchmeier W, et al. Met, metastasis, motility and more. Nat Rev Mol Cell Biol, 2003. 4(12): 915-25.
-
(2003)
Nat Rev Mol Cell Biol
, vol.4
, Issue.12
, pp. 915-925
-
-
Birchmeier, C.1
Birchmeier, W.2
-
8
-
-
77950552463
-
Targeting the HGF/Met signalling pathway in cancer
-
Cecchi F, Rabe D. C, and Bottaro D.P. Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer, 2010. 46(7): 1260-70.
-
(2010)
Eur J Cancer
, vol.46
, Issue.7
, pp. 1260-1270
-
-
Cecchi, F.1
Rabe, D.C.2
Bottaro, D.P.3
-
9
-
-
77956627711
-
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
-
Whittaker S, Marais R, and Zhu A.X. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene, 2010. 29(36): 4989-5005.
-
(2010)
Oncogene
, vol.29
, Issue.36
, pp. 4989-5005
-
-
Whittaker, S.1
Marais, R.2
Zhu, A.X.3
-
10
-
-
58149352266
-
MACC1, a newly identified key regulator of HGF-signaling MET, predicts colon cancer metastasis
-
Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-signaling MET, predicts colon cancer metastasis. Nat Med, 2009. 15(1): 59-67.
-
(2009)
Nat Med
, vol.15
, Issue.1
, pp. 59-67
-
-
Stein, U.1
Walther, W.2
Arlt, F.3
Schwabe, H.4
Smith, J.5
Fichtner, I.6
-
11
-
-
79956115936
-
MACC 1 as a marker for vascular invasive hepatocellular carcinoma
-
Shirahata A, Fan W, Sakuraba K, Yokomizo K, Goto T, Mizukami H, et al. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res, 2011. 31(3): 777-80.
-
(2011)
Anticancer Res
, vol.31
, Issue.3
, pp. 777-780
-
-
Shirahata, A.1
Fan, W.2
Sakuraba, K.3
Yokomizo, K.4
Goto, T.5
Mizukami, H.6
-
12
-
-
80053172942
-
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
-
Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, et al. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med, 2011. 9: 166.
-
(2011)
J Transl Med
, vol.9
, pp. 166
-
-
Qiu, J.1
Huang, P.2
Liu, Q.3
Hong, J.4
Li, B.5
Lu, C.6
-
13
-
-
84863104639
-
Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma
-
Qu J. H, Chang X. J, Lu Y. Y, Bai W. L, Chen Y, Zhou L, et al. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol, 2012. 18(23): 2995-3003.
-
(2012)
World J Gastroenterol
, vol.18
, Issue.23
, pp. 2995-3003
-
-
Qu, J.H.1
Chang, X.J.2
Lu, Y.Y.3
Bai, W.L.4
Chen, Y.5
Zhou, L.6
-
14
-
-
38949128328
-
MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation
-
Wu L. M, Zhang F, Xie H. Y, Xu X, Chen Q. X, Yin S. Y, et al. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation. Clin Genet, 2008. 73(3): 273-8.
-
(2008)
Clin Genet
, vol.73
, Issue.3
, pp. 273-278
-
-
Wu, L.M.1
Zhang, F.2
Xie, H.Y.3
Xu, X.4
Chen, Q.X.5
Yin, S.Y.6
-
15
-
-
77952528214
-
Cancer gene discovery in hepatocellular carcinoma
-
Zender L, Villanueva A, Tovar V, Sia D, Chiang D. Y, and Llovet J.M. Cancer gene discovery in hepatocellular carcinoma. J Hepatol, 2010. 52(6): 921-9.
-
(2010)
J Hepatol
, vol.52
, Issue.6
, pp. 921-929
-
-
Zender, L.1
Villanueva, A.2
Tovar, V.3
Sia, D.4
Chiang, D.Y.5
Llovet, J.M.6
-
16
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996. 334(11): 693-9.
-
(1996)
N Engl J Med
, vol.334
, Issue.11
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
-
17
-
-
0034991518
-
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
-
Yao F. Y, Ferrell L, Bass N. M, Watson J. J, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 2001. 33(6): 1394-403.
-
(2001)
Hepatology
, vol.33
, Issue.6
, pp. 1394-1403
-
-
Yao, F.Y.1
Ferrell, L.2
Bass, N.M.3
Watson, J.J.4
Bacchetti, P.5
Venook, A.6
-
18
-
-
49149114543
-
Liver transplantation for hepatocellular carcinoma: Hangzhou experiences
-
Zheng S. S, Xu X, Wu J, Chen J, Wang W. L, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation, 2008. 85(12): 1726-32.
-
(2008)
Transplantation
, vol.85
, Issue.12
, pp. 1726-1732
-
-
Zheng, S.S.1
Xu, X.2
Wu, J.3
Chen, J.4
Wang, W.L.5
Zhang, M.6
-
19
-
-
58149102321
-
Molecular basis of metastasis
-
Chiang A. C and Massague J. Molecular basis of metastasis. N Engl J Med, 2008. 359(26): 2814-23.
-
(2008)
N Engl J Med
, vol.359
, Issue.26
, pp. 2814-2823
-
-
Chiang, A.C.1
Massague, J.2
-
20
-
-
34247269026
-
Genetic determinants of cancer metastasis
-
Nguyen D. X and Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet, 2007. 8(5): 341-52.
-
(2007)
Nat Rev Genet
, vol.8
, Issue.5
, pp. 341-352
-
-
Nguyen, D.X.1
Massague, J.2
-
21
-
-
79952987944
-
Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence
-
Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg, 2011. 141(4): 895-8.
-
(2011)
J Thorac Cardiovasc Surg
, vol.141
, Issue.4
, pp. 895-898
-
-
Shimokawa, H.1
Uramoto, H.2
Onitsuka, T.3
Chundong, G.4
Hanagiri, T.5
Oyama, T.6
-
22
-
-
0032735443
-
HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells
-
Beviglia L and Kramer R.H. HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells. Int J Cancer, 1999. 83(5): 640-9.
-
(1999)
Int J Cancer
, vol.83
, Issue.5
, pp. 640-649
-
-
Beviglia, L.1
Kramer, R.H.2
-
23
-
-
0032475843
-
Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation
-
Chen H. C, Chan P. C, Tang M. J, Cheng C. H, and Chang T.J. Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J Biol Chem, 1998. 273(40): 25777-82.
-
(1998)
J Biol Chem
, vol.273
, Issue.40
, pp. 25777-25782
-
-
Chen, H.C.1
Chan, P.C.2
Tang, M.J.3
Cheng, C.H.4
Chang, T.J.5
-
24
-
-
0028053831
-
Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells
-
Matsumoto K, Matsumoto K, Nakamura T, and Kramer R.H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem, 1994. 269(50): 31807-13.
-
(1994)
J Biol Chem
, vol.269
, Issue.50
, pp. 31807-31813
-
-
Matsumoto, K.1
Matsumoto, K.2
Nakamura, T.3
Kramer, R.H.4
-
25
-
-
33745220780
-
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
-
Kaposi-Novak P, Lee J. S, Gomez-Quiroz L, Coulouarn C, Factor V. M, and Thorgeirsson S.S. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest, 2006. 116(6): 1582-95.
-
(2006)
J Clin Invest
, vol.116
, Issue.6
, pp. 1582-1595
-
-
Kaposi-Novak, P.1
Lee, J.S.2
Gomez-Quiroz, L.3
Coulouarn, C.4
Factor, V.M.5
Thorgeirsson, S.S.6
-
26
-
-
0345722740
-
Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
-
Park W. S, Dong S. M, Kim S. Y, Na E. Y, Shin M. S, Pi J. H, et al. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res, 1999. 59(2): 307-10.
-
(1999)
Cancer Res
, vol.59
, Issue.2
, pp. 307-310
-
-
Park, W.S.1
Dong, S.M.2
Kim, S.Y.3
Na, E.Y.4
Shin, M.S.5
Pi, J.H.6
-
27
-
-
0031044486
-
Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma
-
Ueki T, Fujimoto J, Suzuki T, Yamamoto H, and Okamoto E. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology, 1997. 25(3): 619-23.
-
(1997)
Hepatology
, vol.25
, Issue.3
, pp. 619-623
-
-
Ueki, T.1
Fujimoto, J.2
Suzuki, T.3
Yamamoto, H.4
Okamoto, E.5
-
28
-
-
24644471128
-
Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
-
Avizienyte E and Frame M.C. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol, 2005. 17(5): 542-7.
-
(2005)
Curr Opin Cell Biol
, vol.17
, Issue.5
, pp. 542-547
-
-
Avizienyte, E.1
Frame, M.C.2
-
29
-
-
36549031307
-
TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling
-
Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res, 2008. 314(1): 143-52.
-
(2008)
Exp Cell Res
, vol.314
, Issue.1
, pp. 143-152
-
-
Cicchini, C.1
Laudadio, I.2
Citarella, F.3
Corazzari, M.4
Steindler, C.5
Conigliaro, A.6
-
30
-
-
84867273359
-
EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-kappaB activation
-
Kiefel H, Bondong S, Pfeifer M, Schirmer U, Erbe-Hoffmann N, Schafer H, et al. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-kappaB activation. Carcinogenesis, 2012. 33(10): 1919-29.
-
(2012)
Carcinogenesis
, vol.33
, Issue.10
, pp. 1919-1929
-
-
Kiefel, H.1
Bondong, S.2
Pfeifer, M.3
Schirmer, U.4
Erbe-Hoffmann, N.5
Schafer, H.6
-
31
-
-
33749024777
-
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis
-
Christiansen J. J and Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res, 2006. 66(17): 8319-26.
-
(2006)
Cancer Res
, vol.66
, Issue.17
, pp. 8319-8326
-
-
Christiansen, J.J.1
Rajasekaran, A.K.2
-
32
-
-
77953285096
-
Molecular signature for HCC: Role in predicting outcomes after liver transplant and selection for potential adjuvant treatment
-
Schmidt C and Marsh J.W. Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment. Curr Opin Organ Transplant, 2010. 15(3): 277-82.
-
(2010)
Curr Opin Organ Transplant
, vol.15
, Issue.3
, pp. 277-282
-
-
Schmidt, C.1
Marsh, J.W.2
-
33
-
-
50549094380
-
Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers
-
Schwartz M, Dvorchik I, Roayaie S, Fiel M. I, Finkelstein S, Marsh J. W, et al. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol, 2008. 49(4): 581-8.
-
(2008)
J Hepatol
, vol.49
, Issue.4
, pp. 581-588
-
-
Schwartz, M.1
Dvorchik, I.2
Roayaie, S.3
Fiel, M.I.4
Finkelstein, S.5
Marsh, J.W.6
|